Diabetes Prevention Program Reauthorization Act of 2024
Latest Action
Referred to the House Committee on Energy and Commerce.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Diabetes Prevention Program Reauthorization Act of 2024 is a legislative proposal introduced in the House during the 118th Congress aimed at reauthorizing funding and support for diabetes prevention programs. The bill was referred to the House Committee on Energy and Commerce but did not advance further and ultimately failed or expired. No official summary or full text is available to provide detailed provisions or funding specifics. The bill falls under the health policy area and appears intended to continue or renew efforts to prevent diabetes through federal programs.
This bill sought to reauthorize diabetes prevention programs but did not progress beyond committee referral and expired without enactment.
- The bill is titled the Diabetes Prevention Program Reauthorization Act of 2024 and was introduced in the House of Representatives.
- It was referred to the House Committee on Energy and Commerce on October 25, 2024.
- The bill ultimately failed or expired without further legislative action or enactment.
['Individuals at risk of diabetes who may receive prevention services', 'Federal health agencies involved in diabetes prevention programs', 'Healthcare providers and organizations engaged in diabetes prevention efforts']
['Lack of available full text and official summary limits understanding of specific provisions and funding mechanisms', 'Failure to advance beyond committee referral suggests potential challenges in legislative support or prioritization', 'Without reauthorization, existing diabetes prevention programs may face funding gaps or operational uncertainty']
The bill was introduced in the 118th Congress and referred to the House Committee on Energy and Commerce, a common committee for health-related legislation. The failure or expiration status indicates it did not receive a vote or further consideration before the end of the congressional session. No additional legislative actions or amendments are recorded.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential disruption or reduction in diabetes prevention services if reauthorization was necessary for funding continuity', 'Possible increased healthcare costs or health impacts if prevention programs lapse due to lack of reauthorization']
The absence of the full bill text and official summary limits transparency and public oversight. The bill's failure to advance beyond committee referral highlights the importance of monitoring legislative progress to understand which health programs receive continued federal support. Future tracking of similar bills should ensure availability of complete legislative documents to facilitate informed analysis.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.